Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation.

@article{Durand2014ComparisonOT,
  title={Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation.},
  author={Eric Durand and Didier Blanchard and St{\'e}phan Chassaing and Martine Gilard and Marc Laskar and Bogdan Borz and Antoine Lafont and Christophe Barbey and Matthieu Godin and Christophe Tron and Rachid Zegdi and Didier Chatel and Olivier le Page and P Y Litzler and Jean-Paul Bessou and Nicolas Danchin and Alain G Cribier and H{\'e}l{\`e}ne Eltchaninoff},
  journal={The American journal of cardiology},
  year={2014},
  volume={113 2},
  pages={355-60}
}
Dual antiplatelet therapy is commonly used in patients undergoing transcatheter aortic valve implantation (TAVI), but the optimal antiplatelet regimen is uncertain and remains to be determined. The objective of this study was to compare 2 strategies of antiplatelet therapy in patients undergoing TAVI. A strategy using monoantiplatelet therapy (group A, n = 164) was prospectively compared with a strategy using dual antiplatelet therapy (group B, n = 128) in 292 consecutive patients undergoing… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS